Skip to main content
Equibles

Ritu Baral

Analyst

TD Cowan

Equibles does not estimate personal net worth.

About Ritu Baral

Ritu Baral is recorded as Analyst at TD Cowan. Ritu Baral has spoken on 4 earnings calls across 3 companies, most recently for Milestone Pharmaceuticals Inc. on November 13, 2026. Those appearances were for Praxis Precision Medicines, Inc. (PRAX), Milestone Pharmaceuticals Inc. (MIST) and INSMED Inc (INSM). The companies whose calls Ritu Baral spoke on are classified in the Healthcare sector.

Ritu Baral on recent calls

“I wanted to ask about how we should be thinking about forward top-line growth. Obviously, the numbers for August and since, well, especially August, have been an improvement over prior numbers and Q2.”
Analyst — T.D. Cowan, Third Quarter 2026 Financial Results ·
“One of the things that we have been watching on Symphony TRX is seemingly an improved compliance rate, or at least fill rate. Can you go over sort of what initiatives you may be conducting to promote compliance?”
Analyst — TD Cowan, INSMED Inc Q2 FY2026 Earnings Call ·
“Marcia, I wanted to dig down into your comment about the mid-cycle, the ULICSA mid-cycle review meeting, if you'll let me. You mentioned the word forward-looking.”
Analyst — TD Cowan, Praxis Precision Medicines Second Quarter 2026 Financial Results Conference Call ·
“A lot of client questions just around the upcoming power readout and what our expectations should be.”
Analyst — TD Cowan, Praxis Precision Medicines, Inc. Q1 FY2026 Earnings Call ·

Affiliation history

  • TD Cowan

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity